CD8A and melanoma: In the melanoma studies, only 2–4 SLPs evoked a neoepitope-specific CD8+ T cell response in the peripheral blood, whereas in the glioblastoma study, only 1 patient generated a CD8+ T cell response to 2 neoepitopes.